Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OrthoPediatrics Corp. - Common Stock (NQ:KIDS)

16.79 -0.50 (-2.89%)
Streaming Delayed Price Updated: 12:45 PM EST, Feb 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about OrthoPediatrics Corp. - Common Stock

< Previous 1 2 3 Next >
News headline image
OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity
OrthoPediatrics partner iotaMotion receives FDA clearance for use of its iotaSOFT® cochlear implant insertion system in patients four years and older 
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Product Launches
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics to Participate in Upcoming Conferences
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Reports Third Quarter 2025 Financial Results
Increased Third Quarter 2025 Revenue 12% Year-over-year, and Increased Adjusted EBITDA by 56% year-over-year 
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Receives FDA approval for 3P™ Pediatric Plating Platform™ Small-Mini System, the second of several systems in the 3P family
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. to Report Third Quarter Financial Results on October 28, 2025
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Announces Preliminary Third Quarter 2025 Revenue and Revised 2025 Guidance
Company to host conference call today, October 9th, 2025, to discuss the financial results and updated outlook 
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spinal Growth Guidance System
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.
Advancing Care for Pediatric Trauma Patients 
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance
Second Quarter 2025 Revenue Surpasses $60 million for the First Time in Company History, and Increased Adjusted EBITDA by 58% year-over-year 
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Announces Continued Expansion of Specialty Bracing Division Into New Territories with Multiple Clinics
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
Global POISE Study Reaches Milestone of 600 Orthopedic Implants in Pediatric Patients, Advancing Research on the Safety and Efficacy of OrthoPediatrics® Products
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting
Reinforced Long-Term Commitment as Emerald Sponsor 
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance
First Quarter 2025 Revenue Increased 17% Year-over-Year 
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ Pediatric Plating Platform™ Hip System
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. to Participate in the 24th Annual Needham Virtual Healthcare Conference
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Named One the 2025 Best Places to Work in Indiana
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2024 and Issues 2025 Financial Guidance
From OrthoPediatrics Corp.
Via GlobeNewswire
News headline image
OrthoPediatrics Corp. Announces Expansion of Specialty Bracing Division
From OrthoPediatrics Corp.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.